Alpha Compute Corp

NasdaqCM:ALP Stock Report

Market Cap: US$5.8m

Alpha Compute Balance Sheet Health

Financial Health criteria checks 5/6

Alpha Compute has a total shareholder equity of $8.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $30.6M and $21.7M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$3.26m
EquityUS$8.88m
Total liabilitiesUS$21.71m
Total assetsUS$30.59m

Recent financial health updates

Recent updates

Seeking Alpha • Aug 29

Portage Biotech GAAP EPS of -$0.13

Portage Biotech press release (NASDAQ:PRTG): Q1 GAAP EPS of -$0.13. As of June 30, 2022, the Company had cash and cash equivalents of approximately $21.2 million.
Seeking Alpha • Jul 20

Portage Biotech rises after getting full ownership of its anti-cancer agonist platform

Portage Biotech (NASDAQ:PRTG) stock has added 16.8% to $10.95 in Wednesday morning trading, after the company said it had acquired the remaining ownership interest in its invariant natural killer T cell (iNKT cell) agonist platform. iNKT cells play an important role in anti-tumor immune responses. PRTG's synthetic iNKT agonists activate and expand important immune system components and immune attacks against cancer. With the acquisition of the about 22% remaining ownership interest, PRTG now fully owns the worldwide rights to its iNKT agonists, including lead programs PORT-2 and PORT-3. The acquisition was done through PRTG's unit iOx Therapeutics from the founding equity holders in exchange for 1.07M shares of Portage (PRTG). Additionally, a payment of $25M in PRTG shares or cash would be triggered upon the achievement of a certain clinical milestone in the PORT-2 or PORT-3 programs.
Seeking Alpha • Jul 06

Portage Biotech acquires Tarus Therapeutics, a developer of adenosine receptor antagonists

Portage Biotech (NASDAQ:PRTG) on Wednesday said it would acquire privately-held Tarus Therapeutics in exchange for about 2.4M PRTG shares and the assumption of $3M in liabilities. The acquisition of Tarus allows PRTG to acquire two clinical-stage adenosine compounds and two preclinical assets for a ~$21M upfront consideration. The deal also calls for additional payments of up to $32M in PRTG shares or cash upon achievement of certain milestones. As per the deal, Robert Glassman, a former independent director of Tarus, will join PRTG's board. PRTG also said it had entered into a committed share purchase agreement for up to $30M with Chicago-based institutional investor Lincoln Park Capital Fund LLC, the proceeds of which will potentially extend PRTG's cash runway into 2024. PRTG stock earlier closed +2.5% at $7.72.

Financial Position Analysis

Short Term Liabilities: ALP's short term assets ($19.0M) do not cover its short term liabilities ($21.5M).

Long Term Liabilities: ALP's short term assets ($19.0M) exceed its long term liabilities ($166.0K).

Debt to Equity History and Analysis

Debt Level: ALP is debt free.

Reducing Debt: ALP has no debt compared to 5 years ago when its debt to equity ratio was 0.2%.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ALP has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: ALP is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/17 16:29
End of Day Share Price 2026/06/17 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alpha Compute Corp is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Justin WalshB. Riley Securities, Inc.
Li Wang WatsekCantor Fitzgerald & Co.
Kevin DedeH.C. Wainwright & Co.